A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study

Conditions: Meningococcal Immunization Interventions: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Tetanus Protein Conjugate Vaccine (TetraMen-T).; Biological: Meningococcal Group C-CRM197 Conjugate Vaccine Sponsors: Sanofi Pasteur, a Sanofi Company Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials